VanEck Associates’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-173,533
Closed -$15.5M 895
2017
Q1
$15.5M Buy
173,533
+24,286
+16% +$2M 0.07% 189
2016
Q4
$10.6M Buy
+149,247
New +$11.1M 0.05% 217
2016
Q2
Sell
-1,424
Closed -$121K 898
2016
Q1
$121K Buy
1,424
+197
+16% +$14.7K ﹤0.01% 656
2015
Q4
$97K Buy
1,227
+401
+49% +$31.6K ﹤0.01% 627
2015
Q3
$58K Buy
826
+125
+18% +$10.3K ﹤0.01% 669
2015
Q2
$63K Buy
+701
New +$67.6K ﹤0.01% 682

Other funds holding MJN

VanEck Associates's MJN Position: Q2 2017 in Review

VanEck Associates sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 173,533 shares — an estimated $15.5M sold.

VanEck Associates first reported a position in MJN in Q2 2015 and held it in 6 quarters. The position peaked at $15.5M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • VanEck Associates reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • VanEck Associates sold 173,533 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $15.5M.
  • VanEck Associates first reported a position in Mead Johnson Nutrition Company in Q2 2015 and held it in 6 quarters.
  • VanEck Associates's Mead Johnson Nutrition Company position peaked at $15.5M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on VanEck Associates's 13F filing for Q2 2017, filed 11 Aug 2017.